Welcome to our dedicated page for GLOBE LIFE SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. reported diluted net income of $3.65 per share for the quarter ended June 30, 2026, up from $3.05 a year earlier, and net operating income of $3.61 per share versus $3.27.
Total premium revenue rose 7% to $1,297,622 thousand, while insurance underwriting income per share increased to $4.69 from $4.28 and excess investment income per share grew to $0.49 from $0.42. Management highlighted double-digit net operating income per share growth in eight of the last nine quarters.
For the six months, net income return on equity was 18.4%. Book value per share was $78.18, and $100.04 excluding accumulated other comprehensive income, up 18% and 11% respectively over the prior-year quarter. The company repurchased 1.1 million shares for $175 million and raised its full-year 2026 diluted EPS guidance to $15.55–$15.95.
GLOBE LIFE INC. executive Dolores L. Skarjune reported a same-day option exercise and share sale. She exercised employee stock options for 1,850 shares of common stock at $103.23 per share, then sold 1,850 shares in an open-market transaction at $179.18 per share.
After these transactions, she directly holds 13,696.734 common shares and has an additional 2,899.424 shares held indirectly through a 401(k) plan. No remaining stock options are shown in this filing, indicating the exercised option grant was fully converted.
Globe Life Inc. notice under Rule 144 reports a proposed sale of 1,850 shares of Common Stock by means of a stock option exercise with proceeds to the seller, dated 06/30/2026. The filing also records 4,175 shares sold in the prior three months for $693,793.98.
Globe Life Inc. has updated its main credit arrangements to extend maturities and increase term loan capacity. The company and subsidiary TMK Re Ltd. entered a Third Amended and Restated Credit Agreement that moves the Administrative Agent role from Bank of America to Wells Fargo and extends the facility’s maturity from March 29, 2029 to June 26, 2031.
Globe Life also executed an Amended and Restated Term Loan Agreement with Wells Fargo as Administrative Agent, increasing the loan’s principal amount from $250,000,000 to $450,000,000 and extending the maturity from August 15, 2027 to June 26, 2029. These agreements continue Globe Life’s lending relationships with a group of banks and are filed as Exhibits 10.1 and 10.2.
GLOBE LIFE INC. director Cheryl Alston exercised stock options and sold shares of common stock. On June 25, 2026, she exercised options for 14,017 shares of common stock at a conversion price of $105.56 per share, increasing her direct holdings. That same day she completed open-market sales totaling 8,258 shares at prices around $177–$181 per share. After these transactions, she directly held 16,621.037 shares of Globe Life common stock. A footnote states this amount includes 26.086 shares acquired through the company’s dividend reinvestment plan since the prior report.
Globe Life Inc. executive Rebecca E. Zorn reported an option exercise and share sale. On June 18, 2026, she exercised 2,000 employee stock options at $98.32 per share and sold 2,000 shares of common stock in open-market transactions at an average price of $170.0967.
After these transactions, she directly holds 17,797.0997 shares of Globe Life common stock and 14,200 remaining employee stock options expiring on February 24, 2028. The sale prices ranged from $169.70 to $170.41 per share.
Globe Life Inc filed a Form 144 notice reporting the sale of 2,000 shares of Common Stock in a stock option exercise on 06/18/2026. The filing also lists prior sales by Rebecca E. Zorn of 8,800 shares on 03/31/2026 for $1,202,189.45.
GLOBE LIFE INC. executive Dolores L. Skarjune reported option exercises combined with open-market sales of company stock. On 2026-06-12, she exercised employee stock options covering 1,700 shares at a strike price of $103.23 per share and 2,475 shares at $98.32 per share, converting derivative awards into common stock. She then sold 874 shares at $167.2530 per share, 1,103 shares at $166.5095 per share, and 2,198 shares at $165.5846 per share in open-market transactions. Following these transactions, she directly holds 15,673.734 shares of common stock and indirectly holds 2,894.735 shares through a 401(k) plan, while the option positions referenced in this filing have been fully exercised.
Globe Life Inc. executive Robert Brian Mitchell, EVP, General Counsel and CRO, reported a bona fide gift of 1,250 shares of Globe Life common stock by the Mitchell Family Trust. After this gift, that trust holds 43,369.3294 shares, while Mitchell also reports additional indirect and direct holdings in Globe Life stock.